Addus HomeCare Q4 EPS Beats by 3.3%, Revenue Rises 25.6% to $373M
Addus HomeCare reported Q4 adjusted EPS of $1.77, beating estimates by 3.3% and up from $1.38 a year ago, while revenue climbed 25.6% to $373.08M, topping forecasts by 0.9%. Personal care revenue surged 29.8% to $285.98M, hospice sales rose 18.7% to $70.0M, while home health revenue dipped 4.1% to $17.1M.
1. Q4 Earnings Beat
Addus HomeCare delivered adjusted EPS of $1.77 for Q4, surpassing the consensus forecast of $1.71 by 3.3% and up from $1.38 in Q4 2024. Revenue reached $373.08 million, marking a 25.6% year-over-year increase and beating estimates by 0.9%.
2. Segment Performance
Personal care services led growth with revenue of $285.98 million, up 29.8% year-over-year and above analyst projections of $282.11 million. Hospice revenue increased 18.7% to $70.0 million, while the home health segment dipped 4.1% to $17.1 million, slightly below the $17.37 million estimate.
3. Outlook and Market Reaction
Shares of Addus HomeCare have risen 7.5% year to date, outperforming the S&P 500’s 0.9% gain. With a hold rating from analysts and mixed segment trends, investors will focus on management’s commentary and next-quarter consensus estimates of $1.55 EPS on $368.63 million revenue.